June 14, 2022
Announcing our partnership with the Punjab Government in collaboration with Roche Pharma India
It is with great pride and honor that we announce Niramai’s partnership with the Punjab Government to contribute to women’s breast health awareness.
It is with great pride and honor that we announce Niramai’s partnership with the Punjab Government to contribute to women’s breast health awareness.
Niramai’s novel Artificial Intelligence-based, radiation-free, automated, non-invasive breast health screening test is called ThermalytixTM. It is a no-touch, no pain, a radiation-free privacy-sensitive screening test that detects breast cancer at an early stage for women of all age groups, whether symptomatic or asymptomatic.
The Punjab government advances the use of ThermalytixTM thus making Punjab the 1st state to offer contactless breast cancer screening and a joint initiative for the same has been commenced. The partnership named “Punjab Breast Cancer AI Digital project”, also known as the ‘Pink project’ is a collaboration among 3 operational institutions with distinctive allotted roles as follows:
- Niramai Health Analytix caters as the breast health screening partner
- Roche India contributes as a referral pathway technical partner
- And the Health Department, Govt. of Punjab is the initiator and fund supporter
This partnership project aims to accelerate breast health awareness through breast screening thus intending to downstage breast Cancer in the state of Punjab. It aids in increasing awareness towards early detection and management of breast cancer.
Roche Products India Limited plays a vital role in this initiative and will act as a Technical Partner for project planning, implementation & monitoring of the state-wide Breast Cancer project plan, thereby strengthening the referral pathway through digitization.
Early detection of Breast Cancer is extremely crucial to reduce mortality rates and provide appropriate treatment pathways on time. This approach intends on screening 15,000 women in a span of one year to accelerate the early-stage diagnosis of breast cancer. Since Niramai’s ThemalytixTM is a low-cost and portable breast screen test, it can be used as the primary screening method conducted by technicians with minimal training in resource-constrained locations as well.
The Punjab government will ensure the mobilization of the population for screenings which would be supported by Niramai Health Analytix & Roche Pharma India. The Punjab screening camp commenced on 15th June 2022 and was inaugurated in presence of:
Director Family Welfare (DFW): Dr. Ranjit Singh Ghotra
Civil Surgeon, District Mohali: Dr. Adarshpal Kaur
Dr. Sandeep (State Programme Officer &Assistant Director, NPCDCS and His team.